Gerd A. Kullak‐Ublick

Novartis (Switzerland) — Switzerland

Medicine · Health Sciences

79h-index25.8kcitations409works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(148), Drug-Induced Hepatotoxicity and Protection(63), Liver Disease Diagnosis and Treatment(53), Pharmacological Effects and Toxicity Studies(50), Pharmacogenetics and Drug Metabolism(38)

Publications403 total

203P Integrating ePROs with EQ-5D quality-of-life measures to enable digital oncology monitoring
ESMO Real World Data and Digital Oncology·2025Open Access
Unsupervised dynamic ePRO reporting of immunotherapy related symptoms in cancer patients
Oncology·2025· 2 cited
Abstract P2-04-21: Dynamic reporting of treatment related symptoms via ePROs can reversely identify the type of underlying cancer
Clinical Cancer Research·2025
Using Machine Learning Approaches on Dynamic Patient-Reported Outcomes to Cluster Cancer Treatment-Related Symptoms
Current Oncology·2025· 1 citedOpen Access
The Role of Folate Receptor α Autoantibodies in Folate Deficiency, Disease Severity, and Treatment Response in Adolescents with Major Depressive Disorder
Journal of Nutrition·2025Open Access
Drug‐Induced Liver Injury Associated With Emerging Cancer Therapies
Liver International·2025· 9 citedOpen Access
Drug-induced cholestasis (DIC) predictions based on in vitro inhibition of major bile acid clearance mechanisms
Archives of Toxicology·2024· 3 cited
1839P Dynamic reporting of treatment related symptoms via ePROs can reversely identify the type of underlying cancer
Annals of Oncology·2024Open Access
Towards an early warning system for monitoring of cancer patients using hybrid interactive machine learning
Frontiers in Digital Health·2024· 5 citedOpen Access
Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC)
Archives of Toxicology·2024· 4 cited
L-carnitine co-administration prevents colistin-induced mitochondrial permeability transition and reduces the risk of acute kidney injury in mice
Scientific Reports·2024· 6 citedOpen Access
Liver toxicity in oncology trials and beyond: a simplified concept for management of hepatocellular drug-induced liver injury in patients with abnormal baseline liver tests
Expert Opinion on Drug Safety·2024· 1 cited
L-carnitine Prevents Colistin-induced Mitochondrial Permeability Transition and Reduces the Risk of Acute Kidney Injury in Mice
2024Open Access
Impact of Electronic Patient-Reported Outcomes on Unplanned Consultations and Hospitalizations in Patients With Cancer Undergoing Systemic Therapy: Results of a Patient-Reported Outcome Study Compared With Matched Retrospective Data
JMIR Formative Research·2024· 3 citedOpen Access
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes
JMIR Cancer·2024· 3 citedOpen Access
Developing a Model for Quantifying QTc-Prolongation Risk to Enhance Medication Safety Assessment: A Retrospective Analysis
Journal of Personalized Medicine·2024· 2 citedOpen Access
Rescue Therapy for Supratherapeutic Concentrations of Calcineurin Inhibitors Using Potent Cytochrome P450 Inducers
Pharmacoepidemiology·2024· 2 citedOpen Access
Autoren
Elsevier eBooks·2024
Toxische Lebererkrankungen
Elsevier eBooks·2024
Impact of Electronic Patient-Reported Outcomes on Unplanned Consultations and Hospitalizations in Patients With Cancer Undergoing Systemic Therapy: Results of a Patient-Reported Outcome Study Compared With Matched Retrospective Data (Preprint)
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Peter J. Meier(16), Bruno Stieger(13), Raúl J. Andrade(8), Guruprasad P. Aithal(7), Bruno Hagenbuch(7), Einar S. Björnsson(6), Ulrich Beuers(6), Christiane Pauli‐Magnus(6), Diana Jung(6), M. Isabel Lucena(5), Michael Fried(5), Yvonne Meier(5), Jyrki J. Eloranta(5), Naga Chalasani(4), Paul B. Watkins(4), Karin Fattinger(4), Luc Biedermann(4), Reinhold Kerb(4), Robert J. Fontana(4), Stephan R. Vavricka(4)